medcomms

  • Public Access to Clinical Trial Lay Summaries: Use, Value, and Medical Writing Considerations

    An educational narrative review from a medical writing perspective By Femi Fajimi | 18 May 2026 Abstract Clinical trial lay summaries have emerged as important tools for improving transparency and public understanding of clinical research following increasing regulatory emphasis on patient-focused communication. Regulatory frameworks such as the European Union Clinical Trials Regulation (EU CTR) No.…

    Read more →

  • Understanding Protocol Amendments: A Beginner’s Perspective  By ‘Femi Fajimi | 14 May 2025  As I continue developing my skills in regulatory medical writing, I’m learning that clinical trial protocols don’t always remain fixed. In practice, they often need to be revised, and that’s where protocol amendments come in.  Understanding amendments has helped me see how…

    Read more →